Partners & Partners, Aviir Ink Deal to Distribute Tests in the Middle East and North Africa | GenomeWeb

NEW YORK (GenomeWeb News) – Partners & Partners will be the sole distributor of Aviir's tests and technologies in 19 countries in the Middle East and North Africa as part of a deal announced today.

P&P will roll out a network, country by country, to distribute and promote Aviir's tests —including the Aviir MIRISK VP Assessment test for assessing an individual's risk for developing a heart attack — through its affiliate Qatar Heart Laboratory Holding, Aviir said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.